Carregant...
DRUG EVALUATION: Pharmacodynamic assessment of vedolizumab for the treatment of ulcerative colitis
INTRODUCTION: Vedolizumab is an anti-integrin approved for the treatment of Crohn’s disease and ulcerative colitis. By binding the α4β7-integrin heterodimer, vedolizumab blocks leukocyte translocation into gastrointestinal tissue. AREAS COVERED: This review discusses the chemistry, pharmacologic pro...
Guardat en:
| Publicat a: | Expert Opin Drug Metab Toxicol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4917449/ https://ncbi.nlm.nih.gov/pubmed/27096357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17425255.2016.1181171 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|